Auxilium Pharmaceuticals Inc. AUXL saw a big move last session, as the company's shares fell nearly 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for AUXL, as the stock is now down about 1% in the past one-month time frame.
The specialty biopharmaceutical company has seen a mixed track record when it comes to current year estimate revisions over the past few weeks with no movement in either side, and the consensus for earnings has moved lower over the last 30 days. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.
AUXL currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is 0.
Some better-ranked stocks in the same sector include Aeolus Pharmaceuticals Inc. (AOLS), Aerie Pharmaceuticals, Inc. AERI and Ariad Pharmaceuticals Inc. ARIA. All these stocks hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AUXILIUM PHARMA AUXL: Free Stock Analysis Report
AEOLUS PHARMACT (AOLS): Get Free Report
AERIE PHARMACT AERI: Get Free Report
ARIAD PHARMA ARIA: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Market News and Data brought to you by Benzinga APIsThe specialty biopharmaceutical company has seen a mixed track record when it comes to current year estimate revisions over the past few weeks with no movement in either side, and the consensus for earnings has moved lower over the last 30 days. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.
AUXL currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is 0.
Some better-ranked stocks in the same sector include Aeolus Pharmaceuticals Inc. (AOLS), Aerie Pharmaceuticals, Inc. AERI and Ariad Pharmaceuticals Inc. ARIA. All these stocks hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AUXILIUM PHARMA AUXL: Free Stock Analysis Report
AEOLUS PHARMACT (AOLS): Get Free Report
AERIE PHARMACT AERI: Get Free Report
ARIAD PHARMA ARIA: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: MoversTrading Ideas
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
